Advertisement

Related Videos

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Feb
17
Today In Oncology
Colorectal Cancer How Does Lifetime Alcohol Consumption Affect Risk
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Can Color Vision Deficiency Impact Survival in Bladder or Colorectal Cancer
Cancer Surgery Outcomes Similar Between Rural and Urban Facilities
Cardiovascular Effects and Risk Factors Identified With BRAF and MEK Inhibition in Melanoma
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo